Regulatory pressure from GxP, 21 CFR Part 11, and AI/ML guidance elevates requirements for audit trails, data lineage, ...
AI is already helping the biopharmaceutical industry to optimize its manufacturing activities, according to IFPMA.
Moving away from fed-batch has significant sustainability and cost-saving benefits, according to industry working groups.
France’s Saint‑Julien site adds a bioprocess development suite for upstream/downstream scale-up of recombinant proteins, ...
Academics innovate gene therapy manufacturing to cut costs and improve access, addressing commercialization challenges and ...
Model N survey finds only 1% of medtech companies have real-time revenue visibility despite 97% using AI, causing margin ...
Strategic Growth in the Pharmaceutical Microbiology QC Market: Trends, Technology, and ComplianceThe global pharmaceutical ...
Explore India's potential to lead the decarbonization of the chemicals industry and tackle pollution challenges effectively.
Artis BioSolutions Establishes U.S.-based Synthetic DNA Manufacturing Hub in Boston Share Expanded facility integrates Syngoi Technologies’ enzymatic DNA platform into Artis’ North American operations ...
Eschbach has been recognised at the 10th IoT Breakthrough Awards for its AI-powered solution SAMI Chat, part of the company’s ...
The Pioneer on MSN
CDSCO pushes dossier-based drug licencing system
India, March 20 -- The Central Drugs Standard Control Organisation (CDSCO) has issued comprehensive guidelines outlining a dossier-based approach for issuance and renewal of drug manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results